ms powerpoint

17
NCSU CCTRP NCSU CCTRP EVALUATION OF NANOPARTICLE EVALUATION OF NANOPARTICLE INTERACTIONS WITH SKIN INTERACTIONS WITH SKIN Nancy Ann Monteiro-Riviere, Ph.D. Nancy Ann Monteiro-Riviere, Ph.D. Professor of Investigative Dermatology and Professor of Investigative Dermatology and Toxicology Toxicology Center for Chemical Toxicology Research Center for Chemical Toxicology Research and Pharmacokinetics and Pharmacokinetics North Carolina State University North Carolina State University Raleigh, NC 27606 Raleigh, NC 27606

Upload: prezi22

Post on 14-Jun-2015

199 views

Category:

Health & Medicine


3 download

TRANSCRIPT

Page 1: MS PowerPoint

NCSU CCTRPNCSU CCTRP

EVALUATION OF EVALUATION OF NANOPARTICLE INTERACTIONS NANOPARTICLE INTERACTIONS

WITH SKINWITH SKIN

Nancy Ann Monteiro-Riviere, Ph.D.Nancy Ann Monteiro-Riviere, Ph.D.Professor of Investigative Dermatology and Professor of Investigative Dermatology and

Toxicology Toxicology

Center for Chemical Toxicology Research and Center for Chemical Toxicology Research and PharmacokineticsPharmacokinetics

North Carolina State UniversityNorth Carolina State University

Raleigh, NC 27606Raleigh, NC 27606

Page 2: MS PowerPoint

NCSU CCTRPNCSU CCTRP

OverviewOverviewFocus of the proposed research is to Focus of the proposed research is to assess the nature of interactions assess the nature of interactions between manufactured nanoparticles between manufactured nanoparticles and the skin. and the skin. Dermal absorptionDermal absorption Cutaneous toxicityCutaneous toxicity Distribution to skin after systemic Distribution to skin after systemic exposureexposure

Page 3: MS PowerPoint

NCSU CCTRPNCSU CCTRP

SkinSkin: PORTAL of entry : PORTAL of entry andand TARGET for toxicity TARGET for toxicity

{

Page 4: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Human SkinHuman Skin

Page 5: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Porcine SkinPorcine Skin

Page 6: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Presently, there is minimal data available on the Presently, there is minimal data available on the interaction of manufactured nanoparticles with interaction of manufactured nanoparticles with the skin.the skin.

Decontamination would be significantly Decontamination would be significantly different than with “traditional” chemical different than with “traditional” chemical exposure since solubilization or dilution might exposure since solubilization or dilution might be less efficacious.be less efficacious.

Basic requirement for a risk assessment Basic requirement for a risk assessment includes information on hazard (e.g. toxicity) as includes information on hazard (e.g. toxicity) as well as exposure (e.g. absorption). This project well as exposure (e.g. absorption). This project should begin to define these boundaries.should begin to define these boundaries.

Page 7: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Nanoparticles to be StudiedNanoparticles to be Studied Carbon Bucky balls and nanotubulesCarbon Bucky balls and nanotubules Iron oxide nanocrystalsIron oxide nanocrystals Cadmium selenide nanocrystals Cadmium selenide nanocrystals

Eight particles types selected to study Eight particles types selected to study effect of size, shape and composition effect of size, shape and composition

Page 8: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Model SystemsModel Systems

Human epidermal keratinocyte cell Human epidermal keratinocyte cell cultureculture

Porcine skin flow through diffusion Porcine skin flow through diffusion cellscells

Isolated Perfused Porcine Skin FlapIsolated Perfused Porcine Skin Flap Systemic uptake from perfusateSystemic uptake from perfusate Assess absorption and toxicity of Assess absorption and toxicity of

interesting particlesinteresting particles

Page 9: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Experimental DesignExperimental Design

Nanoparticles will be applied topically Nanoparticles will be applied topically in three exposure scenariosin three exposure scenarios NeatNeat WaterWater Mineral oilMineral oil

Two DosesTwo Doses

Page 10: MS PowerPoint

NCSU CCTRPNCSU CCTRP

EndpointsEndpoints

Light and Electron MicroscopyLight and Electron Microscopy Cytotoxicity and IL-8 releaseCytotoxicity and IL-8 release

Particles that demonstrate potential Particles that demonstrate potential toxicity or absorption in simpler toxicity or absorption in simpler models will then be studied in the models will then be studied in the IPPSFIPPSF

Page 11: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Page 12: MS PowerPoint

NCSU CCTRPNCSU CCTRP

KERATINOCYTE CYTOKINE NETWORKKERATINOCYTE CYTOKINE NETWORK

Page 13: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Page 14: MS PowerPoint

NCSU CCTRPNCSU CCTRP

Isolated Perfused Porcine Skin Flap (IPPSF)Isolated Perfused Porcine Skin Flap (IPPSF)

Isolated system with control over physiological Isolated system with control over physiological parameters and perfusate compositionparameters and perfusate composition

Intact functional microcirculationIntact functional microcirculation Viable epidermis and dermisViable epidermis and dermis Relatively large dosing areaRelatively large dosing area Predictable extrapolation to Predictable extrapolation to in vivo in vivo Allows for simultaneous assessment of absorption, Allows for simultaneous assessment of absorption,

skin disposition, pharmacokinetics and biomarkers skin disposition, pharmacokinetics and biomarkers of irritation of irritation

Humane alternative animal modelHumane alternative animal model Cost-effective compared to Cost-effective compared to in vivo in vivo studiesstudies

Page 15: MS PowerPoint

NCSU CCTRPNCSU CCTRP

IPPSF Surgery and Perfusion SystemsIPPSF Surgery and Perfusion Systems

Page 16: MS PowerPoint

NCSU CCTRPNCSU CCTRP

IPPSF Closely Parallels IPPSF Closely Parallels In VivoIn Vivo Human Absorption Human Absorption

IPPSF vs In Vivo Human

R2 = 0.91

0

5

10

15

20

25

30

35

0 5 10 15 20 25 30 35 40

IPPSF (% Dose )

In V

ivo

Hu

ma

n (

% D

ose

)

Page 17: MS PowerPoint

NCSU CCTRPNCSU CCTRP

ConclusionConclusion Work should provide data on ability of Work should provide data on ability of

a range of manufactured nanoparticles a range of manufactured nanoparticles to interact with skinto interact with skin

Initial assessment of potential vehicle Initial assessment of potential vehicle effectseffects

Should provide boundaries for a Should provide boundaries for a dermal risk assessment on dermal risk assessment on manufactured nanoparticle exposuremanufactured nanoparticle exposure